Integrative Drug-Target Causal Analysis, Single-Cell Sequencing and In-Vivo Validation for Dissecting Molecular
Huaiyu Sun1, Xuewei Li2, Weixuan Zhao1
1Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin, China.
CNS Neuroscience & Therapeutics
|June 15, 2026
Summary
This study identified four genes linked to focal epilepsy risk, with IL10RA and SUCNR1 showing protective effects and CASP1 and FST increasing risk, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Focal epilepsy is a complex neurological disorder with unmet therapeutic needs.
- Identifying novel drug targets is crucial for developing more effective treatments.
Purpose of the Study:
- To identify and validate novel drug targets for focal epilepsy.
- To investigate the causal relationship between gene expression and focal epilepsy risk.
Main Methods:
- Combined single-cell expression data (GSE190452) with genetic data (eQTLGen alliance).
- Utilized Mendelian randomization and co-localization analyses to assess gene expression's causal role.
- Employed molecular docking for drug interaction analysis and validated findings in an animal model of temporal lobe epilepsy.
Main Results:
- Identified four genes (CASP1, FST, IL10RA, SUCNR1) significantly associated with focal epilepsy risk.
- IL10RA and SUCNR1 demonstrated a protective effect (OR < 1), while CASP1 and FST were associated with increased risk (OR > 1).
- Findings were consistent across FinnGen and UK Biobank cohorts.
Conclusions:
- CASP1, FST, IL10RA, and SUCNR1 represent potential druggable targets for focal epilepsy.
- These genes offer promising avenues for novel therapeutic strategies in epilepsy treatment.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...